Literature DB >> 9890881

Structural and kinetic determinants of aldehyde reduction by aldose reductase.

S Srivastava1, S J Watowich, J M Petrash, S K Srivastava, A Bhatnagar.   

Abstract

Aldose reductase (AR) is a member of the aldo-keto reductase superfamily. Due to its ability to catalyze the formation of sorbitol from glucose during hyperglycemic and hypertonic stress, the aldose-reducing property of AR has been accepted as its main physiological and pathological function. Nonetheless, AR is a poor catalyst for glucose reduction and displays active-site properties unexpected of a carbohydrate-binding protein. We, therefore, examined the catalytic properties of AR with a series of naturally occurring aldehydes, compatible in their hydrophobicity to the large apolar active site of the enzyme. Our results show that recombinant human AR is an efficient catalyst for the reduction of medium- to long-chain unbranched saturated and unsaturated aldehydes. The enzyme displayed selective preference for saturated aldehydes, such as hexanal, and unsaturated aldehydes, such as trans-2-octenal and nonenal as well as their 4-hydroxy derivatives. Short-chain aldehydes such as propanal and acrolein were reduced less efficiently. Branched derivatives of acrolein or its glutathione conjugate (GS-propanal) were, however, reduced with high efficiency. In the absence of NADPH, the alpha, beta unsaturated aldehydes caused covalent modification of the enzyme. On the basis of electrospray mass spectrometric analysis of the wild-type and site-directed mutants of AR (in which the solvent exposed cysteines were individually replaced with serine), the site of modification was identified to be the active-site residue, Cys 298. The unsaturated aldehydes, however, did not modify the enzyme bound to NADPH and did not inactivate the enzyme during catalysis. Modeling studies indicate that the large hydrophobic active site of AR can accommodate a large number of aldehydes without changes in the structure of the binding site or movement of side chains. High hydrophobicity due to long alkyl chains or apolar substituents appears to stabilize the interaction of the aldehyde substrates with the enzyme. Apparently, such hydrophobic interactions provide substrate selectivity and catalytic efficiency of the order achievable by hydrogen bonding. Since several of the aldehydes reduced by AR are either environmental and pharmacological pollutants or products of lipid peroxidation, the present studies provide the basis of future investigations on the role of AR in regulating aldehyde metabolism particularly under pathological states associated with oxidative stress and/or aldehyde toxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890881     DOI: 10.1021/bi981794l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells.

Authors:  Jingjing Zhao; Tao Jiang; Hui Li; Yuejuan Zhang; Nong Zhang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids.

Authors:  Karin Wetzelberger; Shahid P Baba; Mahesh Thirunavukkarasu; Ye-Shih Ho; Nilanjana Maulik; Oleg A Barski; Daniel J Conklin; Aruni Bhatnagar
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 3.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

Review 4.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

5.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.

Authors:  Rachel J Keith; Petra Haberzettl; Elena Vladykovskaya; Bradford G Hill; Karin Kaiserova; Sanjay Srivastava; Oleg Barski; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2008-11-11       Impact factor: 5.192

Review 6.  Detoxification reactions: relevance to aging.

Authors:  Piotr Zimniak
Journal:  Ageing Res Rev       Date:  2008-05-02       Impact factor: 10.895

Review 7.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

8.  Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice.

Authors:  Shahid P Baba; Deqing Zhang; Mahavir Singh; Sujith Dassanayaka; Zhengzhi Xie; Ganapathy Jagatheesan; Jingjing Zhao; Virginia K Schmidtke; Kenneth R Brittian; Michael L Merchant; Daniel J Conklin; Steven P Jones; Aruni Bhatnagar
Journal:  J Mol Cell Cardiol       Date:  2018-04-05       Impact factor: 5.000

9.  Protein modification by acrolein: formation and stability of cysteine adducts.

Authors:  Jian Cai; Aruni Bhatnagar; William M Pierce
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

Review 10.  Aldose reductase: a novel therapeutic target for inflammatory pathologies.

Authors:  Kota V Ramana; Satish K Srivastava
Journal:  Int J Biochem Cell Biol       Date:  2009-09-22       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.